Voya Investment Management LLC Atreca, Inc. Transaction History

Voya Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $15,782 - $32,880	-10,117 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $5,794 - $12,699	-2,019 Reduced 16.64%	10,117 $31,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $11,581 - $20,437	-1,481 Reduced 10.88%	12,136 $103,000
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $10,790 - $16,052	830 Added 6.49%	13,617 $209,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $166,614 - $218,529	12,787 New	12,787 $207,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.